These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 18254260)

  • 21. How adiponectin, leptin, and ghrelin orchestrate together and correlate with the severity of nonalcoholic fatty liver disease.
    Machado MV; Coutinho J; Carepa F; Costa A; Proença H; Cortez-Pinto H
    Eur J Gastroenterol Hepatol; 2012 Oct; 24(10):1166-72. PubMed ID: 22735605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass.
    Larson SP; Bowers SP; Palekar NA; Ward JA; Pulcini JP; Harrison SA
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1329-32. PubMed ID: 17702661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy.
    Alqahtani A; Elahmedi M; Alswat K; Arafah M; Fagih M; Lee J
    Surg Obes Relat Dis; 2017 Sep; 13(9):1599-1609. PubMed ID: 28600116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated?
    Helling TS; Helzberg JH; Nachnani JS; Gurram K
    Surg Obes Relat Dis; 2008; 4(5):612-7. PubMed ID: 18226970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass.
    Boza C; Riquelme A; Ibañez L; Duarte I; Norero E; Viviani P; Soza A; Fernandez JI; Raddatz A; Guzman S; Arrese M
    Obes Surg; 2005 Sep; 15(8):1148-53. PubMed ID: 16197788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver visfatin expression in morbidly obese patients with nonalcoholic fatty liver disease undergoing bariatric surgery.
    Kukla M; Ciupińska-Kajor M; Kajor M; Wyleżoł M; Żwirska-Korczala K; Hartleb M; Berdowska A; Mazur W
    Pol J Pathol; 2010; 61(3):147-53. PubMed ID: 21225497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonalcoholic fatty liver disease in severely obese subjects.
    Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
    Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonalcoholic steatohepatitis in morbid obese patients: coffee consumption vs. disease severity.
    Barros RK; Cotrim HP; Daltro C; Alves E; de Freitas LA; Daltro C; Oliveira Y
    Ann Hepatol; 2016; 15(3):350-5. PubMed ID: 27049488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease.
    Abrams GA; Kunde SS; Lazenby AJ; Clements RH
    Hepatology; 2004 Aug; 40(2):475-83. PubMed ID: 15368453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonalcoholic fatty liver disease in severely obese adolescent and adult patients.
    Holterman AX; Guzman G; Fantuzzi G; Wang H; Aigner K; Browne A; Holterman M
    Obesity (Silver Spring); 2013 Mar; 21(3):591-7. PubMed ID: 23592668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonalcoholic fatty liver disease and bariatric surgery in adolescents.
    Holterman A; Gurria J; Tanpure S; DiSomma N
    Semin Pediatr Surg; 2014 Feb; 23(1):49-57. PubMed ID: 24491369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laparoscopic bariatric surgery: what else are we uncovering? Liver pathology and preoperative indicators of advanced liver disease in morbidly obese patients.
    Kroh M; Liu R; Chand B
    Surg Endosc; 2007 Nov; 21(11):1957-60. PubMed ID: 17479322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-invasive Evaluation of NAFLD with Indocyanine Green Clearance Test: a Preliminary Study in Morbidly Obese Patients Undergoing Bariatric Surgery.
    Danin PE; Anty R; Patouraux S; Raucoules-Aimé M; Gugenheim J; Tran A; Gual P; Iannelli A
    Obes Surg; 2018 Mar; 28(3):735-742. PubMed ID: 28875438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome.
    Qureshi K; Abrams GA
    Clin Obes; 2016 Apr; 6(2):117-23. PubMed ID: 26856683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
    Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
    World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients.
    Shalhub S; Parsee A; Gallagher SF; Haines KL; Willkomm C; Brantley SG; Pinkas H; Saff-Koche L; Murr MM
    Obes Surg; 2004 Jan; 14(1):54-9. PubMed ID: 14980034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of light-to-moderate alcohol consumption on steatosis and steatohepatitis in severely obese patients.
    Cotrim HP; Freitas LA; Alves E; Almeida A; May DS; Caldwell S
    Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):969-72. PubMed ID: 19194305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Influence of bariatric surgery on the non-alcoholic liver steatosis. A histological evaluation].
    Ferrer Márquez M; Carvia Pousaillè C; Velasco Albendea J; Rico Morales Mdel M; Casado Martín M; Belda Lozano R; Ferrer Ayza M
    Cir Esp; 2009 Aug; 86(2):94-100. PubMed ID: 19560754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonalcoholic fatty liver disease treated by gastroplasty.
    Jaskiewicz K; Raczynska S; Rzepko R; Sledziński Z
    Dig Dis Sci; 2006 Jan; 51(1):21-6. PubMed ID: 16416204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.